A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium.
Saved in:
| Title: | A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium. |
|---|---|
| Authors: | Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan. t.yanagisawa.jikei@gmail.com.; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. t.yanagisawa.jikei@gmail.com., Mori K; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan.; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Kawada T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Katayama S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan., Maenosono R; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan., Toyoda S; Department of Urology, Faculty of Medicine, Kindai University, Higashi-osaka, Japan., Nukaya T; Department of Urology, Fujita-Health University School of Medicine, Toyoake, Japan., Morinaka H; Department of Urology, Kawasaki Medical School, Kurashiki, Japan., Tamura K; Department of Urology, Hamamatsu Medical University, Hamamatsu, Japan., Fukuokaya W; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan., Murakami M; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan., Bekku K; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Takahara K; Department of Urology, Fujita-Health University School of Medicine, Toyoake, Japan., Fujita K; Department of Urology, Faculty of Medicine, Kindai University, Higashi-osaka, Japan., Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan., Araki M; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Inamoto T; Department of Urology, Hamamatsu Medical University, Hamamatsu, Japan., Komura K; Department of Urology, Kawasaki Medical School, Kurashiki, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan. |
| Corporate Authors: | JK-FOOT study group |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Feb 25; Vol. 75 (3). Date of Electronic Publication: 2026 Feb 25. |
| Publication Type: | Journal Article; Comparative Study; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41739193 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yanagisawa+T%22">Yanagisawa T</searchLink>; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan. t.yanagisawa.jikei@gmail.com.; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. t.yanagisawa.jikei@gmail.com.<br /><searchLink fieldCode="AU" term="%22Mori+K%22">Mori K</searchLink>; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan.; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Kawada+T%22">Kawada T</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Katayama+S%22">Katayama S</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Tsujino+T%22">Tsujino T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.<br /><searchLink fieldCode="AU" term="%22Maenosono+R%22">Maenosono R</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.<br /><searchLink fieldCode="AU" term="%22Toyoda+S%22">Toyoda S</searchLink>; Department of Urology, Faculty of Medicine, Kindai University, Higashi-osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nukaya+T%22">Nukaya T</searchLink>; Department of Urology, Fujita-Health University School of Medicine, Toyoake, Japan.<br /><searchLink fieldCode="AU" term="%22Morinaka+H%22">Morinaka H</searchLink>; Department of Urology, Kawasaki Medical School, Kurashiki, Japan.<br /><searchLink fieldCode="AU" term="%22Tamura+K%22">Tamura K</searchLink>; Department of Urology, Hamamatsu Medical University, Hamamatsu, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuokaya+W%22">Fukuokaya W</searchLink>; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan.<br /><searchLink fieldCode="AU" term="%22Urabe+F%22">Urabe F</searchLink>; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan.<br /><searchLink fieldCode="AU" term="%22Murakami+M%22">Murakami M</searchLink>; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan.<br /><searchLink fieldCode="AU" term="%22Bekku+K%22">Bekku K</searchLink>; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Takahara+K%22">Takahara K</searchLink>; Department of Urology, Fujita-Health University School of Medicine, Toyoake, Japan.<br /><searchLink fieldCode="AU" term="%22Fujita+K%22">Fujita K</searchLink>; Department of Urology, Faculty of Medicine, Kindai University, Higashi-osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Azuma+H%22">Azuma H</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.<br /><searchLink fieldCode="AU" term="%22Araki+M%22">Araki M</searchLink>; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Inamoto+T%22">Inamoto T</searchLink>; Department of Urology, Hamamatsu Medical University, Hamamatsu, Japan.<br /><searchLink fieldCode="AU" term="%22Komura+K%22">Komura K</searchLink>; Department of Urology, Kawasaki Medical School, Kurashiki, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+T%22">Kimura T</searchLink>; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Japan. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22JK-FOOT+study+group%22">JK-FOOT study group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2026 Feb 25; Vol. 75 (3). <i>Date of Electronic Publication: </i>2026 Feb 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41739193 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00262-025-04288-6 Languages: – Code: eng Text: English Titles: – TitleFull: A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yanagisawa T – PersonEntity: Name: NameFull: Mori K – PersonEntity: Name: NameFull: Kawada T – PersonEntity: Name: NameFull: Katayama S – PersonEntity: Name: NameFull: Tsujino T – PersonEntity: Name: NameFull: Maenosono R – PersonEntity: Name: NameFull: Toyoda S – PersonEntity: Name: NameFull: Nukaya T – PersonEntity: Name: NameFull: Morinaka H – PersonEntity: Name: NameFull: Tamura K – PersonEntity: Name: NameFull: Fukuokaya W – PersonEntity: Name: NameFull: Urabe F – PersonEntity: Name: NameFull: Murakami M – PersonEntity: Name: NameFull: Bekku K – PersonEntity: Name: NameFull: Takahara K – PersonEntity: Name: NameFull: Fujita K – PersonEntity: Name: NameFull: Azuma H – PersonEntity: Name: NameFull: Araki M – PersonEntity: Name: NameFull: Inamoto T – PersonEntity: Name: NameFull: Komura K – PersonEntity: Name: NameFull: Kimura T IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 02 Text: 2026 Feb 25 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0851 Numbering: – Type: volume Value: 75 – Type: issue Value: 3 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |
